2024. The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status. Biomolecules and Biomedicine. 24, 2 (Mar. 2024), 256–261. DOI:https://doi.org/10.17305/bb.2023.9868.